Physician profile
Preethi Kumar
NPI 1205222437
$817.61
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $15.53.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $131.00 | 2019 | |
| Amgen INC. | $109.62 | 2019 | |
| Amarin Pharma, INC. | $102.16 | 2019 | |
| Novo Nordisk INC | $83.81 | 2019 | |
| Merck Sharp & Dohme LLC | $72.75 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $57.93 | 2019 | |
| Arbor Pharmaceuticals, INC. | $57.12 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $55.58 | 2019 | |
| Genentech USA, INC. | $28.39 | 2019 | |
| Sanofi-Aventis U.S. LLC | $25.16 | 2019 | |
| Pfizer INC. | $24.75 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.53 | 2020 | |
| Smith+Nephew, INC. | $15.00 | 2019 | |
| Abbvie INC. | $14.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.69 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preethi Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.